Biotechnology, Pharmacology, Medicine, Gene therapy, Therapy, Pharmaceutical industry
Samantha Truex officially unwraps Upstream Bio, her secretive, OrbiMed-backed biotech with $200M in the bank
After Samantha Truex shut down Quench Bio early last year, she knew she wanted to get back into the biotech world and run another company. The path just ended up more winding than initially expected. Truex had joined Atlas Ventures a couple months after Quench closed up shop, and the
Samantha Truex officially unwraps Upstream Bio, her secretive, OrbiMed-backed biotech with $200M in the bank
After Samantha Truex shut down Quench Bio early last year, she knew she wanted to get back into the biotech world and run another company. The path just ended up more winding than initially ...
We are sorry, we could not find the related article
If you are curious about Biotech and Career and Jobs
Please click on:
Subscribe to Biotech - Career and Jobs
Gilead poaches new pharma development and manufacturing chief from cell therapy 2.0 player
Gilead has raided one of the up-and-coming cell therapy 2.0 biotechs to find its new head of pharma development and manufacturing. Dan O’Day’s pharma player has recruited Stacey Ma from ...
Evonik to Build $220M Lipid Plant in U.S. for mRNA-Based Therapies
In partnership with the U.S. government, Evonik Industries is investing more than $200 million to build a lipid manufacturing facility in the United States.
For pharma services firms, big assets can pose major risks
Despite a spotty track record, contract development and manufacturing organizations push on in their acquisition of drugmakers' factories
Book traversal links for The top 10 largest biopharma M&A deals in 2019
Biopharma M&A got a big boost moneywise in 2019. The three largest delivered more than $150 billion, with Bristol-Myers Squibb's $74 billion takeover of Celgene setting a new record. ...
The Biggest European Biotech News of 2021
In spite of the challenges posed by the Covid-19 pandemic, the European biotech industry has emerged stronger than ever this year. These were the key moments for the sector in 2021.
Teesside factory making Covid vaccine gets £400m injection
Japanese owner makes single biggest investment in UK pharmaceutical manufacturing in decades
Is AI delivering on the hype?
AI was flagged as the most disruptive technology in the pharmaceutical sector. AI has been deployed across the pharma value chain, from drug discovery and repurposing, clinical trial design ...
Biotech Roundup: BIO on Racism, AbbVie Antibodies, IPO Surge & More
At the start of 2020 thousands of biotechies anticipated spending the second week of June in San Diego, hobnobbing at the annual conference hosted by the